Wnt1 controls subchondral bone remodeling and osteoarthritis progression
Authors:
- Weixin XieWXWeixin Xie
- Antonia DonatADAntonia Donat
- Shan JiangSJShan Jiang
- Haoyan PanHPHaoyan Pan
- Ruben AugustinRARuben Augustin
- Till SchoberwalterTSTill Schoberwalter
- Chiara GerrietsCGChiara Gerriets
- Jan SeveckeJSJan Sevecke
- Cordula ErdmannCECordula Erdmann
- Saskia SchröderSSSaskia Schröder
- Assil-Ramin AlimyAAAssil-Ramin Alimy
- Isabell BehrensIBIsabell Behrens
Open Access
- 20 November 2026
- journal article
- Published by Springer Nature in Bone Research
- Vol. 14 (1)
Abstract
Despite mounting evidence emphasizing the role of abnormal subchondral bone remodeling in the progression of osteoarthritis (OA), clinical translation has produced disappointing results. Here, we demonstrate an increased expression of Wnt1, a key Wnt ligand with potent osteoanabolic effects, during OA progression in human and murine subchondral bone. Temporarily overexpressing Wnt1 in osteoblasts in the early phase after anterior cruciate ligament transection (ACLT)-induced OA has no effect on cartilage degeneration; however, it contributes to increased subchondral bone mass and alleviates subchondral bone loss. In contrast, late-phase induction of Wnt1 in osteoblasts exacerbates OA severity by inducing aberrant subchondral bone sclerosis, where inflammation-induced secreted frizzled-related protein 2 (Sfrp2) in the subchondral bone potentiates the harmful effects of Wnt1. Moreover, mice with a global inactivating Wnt1 G177C mutation, which clinically causes osteogenesis imperfecta type XV, display low subchondral bone mass, are resistant to ACLT-induced subchondral bone loss and exhibit attenuated OA progression. Taken together, these findings identify a pathophysiological role for Wnt1 in subchondral bone remodeling and OA progression that could represent a promising therapeutic target.Funding Information
- Deutsche Forschungsgemeinschaft (KE 2179/11-1)
- Deutsche Forschungsgemeinschaft (RO 5925/5-1)
- Deutsche Forschungsgemeinschaft (BA 7863/1-1)
This publication has 106 references indexed in Scilit:
- Diagnosis and Treatment of Hip and Knee OsteoarthritisJAMA, 2021
- Cartilage MicroRNA Dysregulation During the Onset and Progression of Mouse Osteoarthritis Is Independent of Aggrecanolysis and Overlaps With Candidates From End‐Stage Human DiseaseArthritis & Rheumatology, 2018
- Subchondral Trabecular Rod Loss and Plate Thickening in the Development of OsteoarthritisJournal of Bone and Mineral Research, 2017
- Depletion of Protease‐Activated Receptor 2 but Not Protease‐Activated Receptor 1 May Confer Protection Against Osteoarthritis in Mice Through Extracartilaginous MechanismsArthritis & Rheumatology, 2014
- Dkk‐1–Mediated Inhibition of Wnt Signaling in Bone Ameliorates Osteoarthritis in MiceArthritis & Rheumatology, 2014
- Guidelines for assessment of bone microstructure in rodents using micro–computed tomographyJournal of Bone and Mineral Research, 2010
- Matrix metalloproteinase 13–deficient mice are resistant to osteoarthritic cartilage erosion but not chondrocyte hypertrophy or osteophyte developmentArthritis & Rheumatism, 2009
- Involvement of the Wnt signaling pathway in experimental and human osteoarthritis: Prominent role of Wnt‐induced signaling protein 1Arthritis & Rheumatism, 2009
- Inhibition of β‐catenin signaling in articular chondrocytes results in articular cartilage destructionArthritis & Rheumatism, 2008
- Resemblance of osteophytes in experimental osteoarthritis to transforming growth factor β–induced osteophytes: Limited role of bone morphogenetic protein in early osteoarthritic osteophyte formationArthritis & Rheumatism, 2007